- 中文名稱
Anti-Human BMP-8
- 英文名字
- Anti-Human BMP-8
- 供應商
- ReliaTech
- 產品貨號
- 101-M239
- 產品報價
- ￥詢價/100ug
- 產品說明書
- 點擊查看
- 購買方式
- 90%產品中國有現貨庫存。銀行轉賬、電匯、支票、現金，在線支付寶及網銀支付，或直接與我們電話聯系400-6800-868
- 產品新聞
- 背景資料
- BMP8, also known as osteogenic protein 2 (OP2), was first isolated from a hippocampal library in a screen to identify relatives of BMP7/ OP1. BMPs are a family of structurally and functionally related proteins and represent a subfamily of the transforming growth factor β (TGFβ) superfamily. BMPs are involved in a wide range of processes including embryogenesis, tissue morphogenesis, cell differentiation and migration, and tumorigenesis. Cellular responses to BMPs are mediated by heterooligomeric complexes of type I and type II serine/threonine kinase receptors . BMP8a and BMP8b, produced from separate genes, share 98% aa sequence identity in human but only 74% in mouse within the mature regions. Human BMP8a is synthesized as a 402 aa precursor protein that is cleaved between Arg263 and Ala264 to release the Cterminal mature protein. Mature human BMP 8a shares 90% and 68% aa sequence identity with mouse mature BMP8a and 8b, respectively. BMP8a is expressed during pregnancy in the deciduum and trophoblast cells, by inner root sheath cells of developing hair follicles, and by the epididymis and spermatids). In the mouse it cooperates with BMP7 in the maintenance of spermatogenesis but is not required for the initiation of spermatogenesis (7, 8). BMP8b, in contrast, is required for both the initiation and maintenance of spermatogenesis. BMP8a is induced during osteoblast differentiation at the onset of mineralization and during the osteogenic phase of bone repair in osteoblasts and osteocytes (1012). BMP8a/b is also highly expressed in osteosarcomas.
- 應用類型
- WB
- 免疫原
- 該Anti-Human BMP-8的詳細信息查看ReliaTech提供的產品說明書。
- 來源宿主
- 該Anti-Human BMP-8的詳細信息查看ReliaTech提供的產品說明書。
- 反應性
- 該Anti-Human BMP-8的詳細信息查看ReliaTech提供的產品說明書。
- 保存建議
- 該Anti-Human BMP-8的詳細信息查看ReliaTech提供的產品說明書。溶解建議：Centrifuge vial prior to opening. Reconstitute the antibody with 500 μl sterile PBS and the final concentration is 200 μg/ml.
- 其他
- ReliaTech全稱為受體配體技術有限公司 (Receptor Ligand Technologies GmbH)，1999年成立，總部位于德國不倫瑞克，是一家后基因組生物技術公司。ReliaTech主要專注于受體和配體的發現與研究。此外，ReliaTech也開發應用于血管與淋巴管生成研究的相關高品質試劑。目前ReliaTech提供近2800款產品，產品線主要包括重組蛋白(細胞因子、生長因子、可溶性受體)、抗體、ELISA試劑盒等。
- 注意
-
該頁面的中文產品信息的翻譯，僅供參考。準確的產品信息請以廠家的英文說明書為準。下單前，請瀏覽說明書確認。
-
